Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Peiper

Showing results (221-230 of 239) with videos related to

Pageof 24
Sort By:
Journal of Virology|August 10, 1999
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infectionT Murakami, T Y Zhang, Y Koyanagi, et al.
Oncotarget|October 1, 2024
Correction: Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Oncotarget|May 26, 2016
Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 1997
Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domainsZ Lu, J F Berson, Y Chen, et al.
Angewandte Chemie (International Ed. in English)|July 24, 2003
Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based librariesNobutaka Fujii, Shinya Oishi, Kenichi Hiramatsu, et al.
Blood|September 3, 2010
Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonistsAditya Mandawat, Warren Fiskus, Kathleen M Buckley, et al.
Journal of the National Cancer Institute|February 22, 2007
Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancyKevin T Nash, Pushkar A Phadke, Jean-Marc Navenot, et al.
American Journal of Clinical Oncology|April 12, 2019
Rapid Early Tumor Progression is Prognostic in Glioblastoma PatientsJoshua D Palmer, Deepak Bhamidipati, Gaurav Shukla, et al.
Journal of Virology|September 1, 1997
Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1B J Doranz, Z H Lu, J Rucker, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strainsA L Edinger, A Amedee, K Miller, et al.
Pageof 24

Showing results (221-230 of 239) with videos related to

Sort By:
Pageof 24
Journal of Virology|August 10, 1999
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infectionT Murakami, T Y Zhang, Y Koyanagi, et al.
Oncotarget|October 1, 2024
Correction: Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Oncotarget|May 26, 2016
Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 1997
Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domainsZ Lu, J F Berson, Y Chen, et al.
Angewandte Chemie (International Ed. in English)|July 24, 2003
Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based librariesNobutaka Fujii, Shinya Oishi, Kenichi Hiramatsu, et al.
Blood|September 3, 2010
Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonistsAditya Mandawat, Warren Fiskus, Kathleen M Buckley, et al.
Journal of the National Cancer Institute|February 22, 2007
Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancyKevin T Nash, Pushkar A Phadke, Jean-Marc Navenot, et al.
American Journal of Clinical Oncology|April 12, 2019
Rapid Early Tumor Progression is Prognostic in Glioblastoma PatientsJoshua D Palmer, Deepak Bhamidipati, Gaurav Shukla, et al.
Journal of Virology|September 1, 1997
Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1B J Doranz, Z H Lu, J Rucker, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strainsA L Edinger, A Amedee, K Miller, et al.
Pageof 24